tiprankstipranks
Trending News
More News >
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market

SynAct Pharma AB (SYNACT) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
SynAct Pharma AB’s (SYNACT) Moving Averages Convergence Divergence (MACD) indicator is -0.73, suggesting SynAct Pharma AB is a Buy.
SynAct Pharma AB’s (SYNACT) 20-Day exponential moving average is 19.46, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) 50-Day exponential moving average is 20.43, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.

SynAct Pharma AB (SYNACT) Pivot Points

Mar 06, 2026, 08:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.55
17.03
17.41
17.89
18.27
18.75
19.13
Fibonacci
17.03
17.36
17.56
17.89
18.22
18.42
18.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (SYNACT) Moving Averages

Mar 06, 2026, 08:29 PM
Period
Simple
Exponential
MA5
18.83Sell
18.58Sell
MA10
19.07Sell
18.90Sell
MA20
19.35Sell
19.46Sell
MA50
21.09Sell
20.43Sell
MA100
21.40Sell
20.71Sell
MA200
20.33Sell
20.08Sell
SynAct Pharma AB’s (SYNACT) 10-Day exponential moving average is 18.90, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) 100-Day exponential moving average is 20.71, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 50-day simple moving average is 21.09, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 100-day simple moving average is 21.40, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 200-day simple moving average is 20.33, creating a Sell signal.

SynAct Pharma AB (SYNACT) Technical Indicators

Mar 06, 2026, 08:29 PM
Name
Value
Implied Action
RSI (14)
37.97
Neutral
STOCH (9,6)
30.67
Neutral
STOCHRSI (14)
26.62
Neutral
MACD (12,26)
-0.73
Buy
ADX (14)
12.72
Buy
Williams %R
-72.34
Buy
CCI (14)
-110.92
Buy
ATR (14)
0.95
-
Ultimate Oscillator
52.46
Neutral
ROC
-3.09
Sell
SynAct Pharma AB’s (SYNACT) Relative Strength Index (RSI) is 37.97, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Trend Strength Indicator (ADX) is 12.72, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) Commodity Channel Index (CCI) is -110.92, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) Price Rate of Change (ROC) is -3.09, creating a Sell signal.

FAQ

Is SYNACT a Buy, Hold, or Sell?
Based on SYNACT’s technical indicators, SYNACT is a Sell.
    What is SYNACT’s RSI (14)?
    SYNACT’s RSI (14) is 37.97, which suggests SYNACT is a Neutral.
      What is SYNACT’s MACD?
      SYNACT’s MACD is -0.73, which suggests SYNACT is a Buy.
        What is SYNACT’s 5-day moving average?
        SYNACT’s 5-day moving average is 18.83, which suggests SYNACT is a Sell.
          What is SYNACT’s 20-day moving average?
          SYNACT 20-day moving average is 19.35, which suggests SYNACT is a Sell.
            What is SYNACT’s 50-day moving average?
            SYNACT’s 50-day moving average is 21.09, which suggests SYNACT is a Sell.
              What is SYNACT’s 200-day moving average?
              SYNACT’s 200-day moving average is 20.33, which suggests SYNACT is a Sell.
                What is SYNACT’s Williams % R (14)?
                SYNACT’s Williams % R (14) is -72.34, which suggests SYNACT is a Buy.
                  What is SYNACT’s CCI (14)?
                  SYNACT’s CCI (14) is -110.92, which suggests SYNACT is a Buy.
                    What is the share price of SynAct Pharma AB?